"We need society to know about our research so that it is adequately funded". This was one of the statements made by Professor María Ujué Moreno, a researcher in the Cardiovascular Diseases Program at research center Applied Medicine at the University of Navarra (CIMA), during the seminar she gave to students, professors and members of the group 'Science, reason and faith' at the academic center.

In his speech, which focused on "research biomedical and personalized medicine in heart failure", he explained that heart failure (HF) is a medical need that presents difficulties in terms of care due to its increasing prevalence, poor prognosis and expense partner -healthcare: "It is the fifth cause of mortality in Spain and is also the leading cause of hospitalization in people over 65 years of age". He also recalled that it is a disease that is difficult to identify because many patients do not go to the doctor thinking that it is an ailment of aging.

He emphasized the need for economic resources for research, given the high mortality rate: "We are not yet at a status where all the parameters are taken into account for treatment to be effective. We must do more research, to learn more".

In this regard, Professor Moreno advocates early and individualized prevention, given that the risk of each person is not the same; early, personalized and precise diagnosis, as in the case of other diseases such as cancer; and specific, safe and effective treatment. To this end, he advocated joint responsibility between patients, researchers, industry, governments and agencies.

María de Ujué Moreno, has a degree in Biochemistry and a PhD in Cell and Molecular Biology from the University of Navarra. After a postdoctoral stay at the BHF-Glasgow Cardiovascular Research Centre, she joined the Cardiovascular Disease Program at CIMA. In the laboratory of Myocardial Remodeling and Heart Failure he investigates the molecular and cellular instructions of the myocardial alterations that underlie heart failure, to identify mechanisms that allow early diagnosis and specific, effective and safe treatment of this pathology. She is a member of group of research BIOMARCS of the University of Navarra and of research center Biomédica en network Cardiovascular. She is the author of more than 40 indexed articles and collaborates in national and European research projects. She is a collaborating professor at School de Ciencias.